Copy-number variants and polygenic risk for intelligence confer risk for autism spectrum disorder irrespective of their effects on cognitive ability.

ASD autism spectrum disorders CNV (copy number variant) cognitive abilities intelligence quotient (IQ) polygenic risk score (PRS)

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2024
Historique:
received: 12 01 2024
accepted: 05 04 2024
medline: 16 5 2024
pubmed: 16 5 2024
entrez: 16 5 2024
Statut: epublish

Résumé

Rare copy number variants (CNVs) and polygenic risk for intelligence (PRS-IQ) both confer susceptibility for autism spectrum disorder (ASD) but have opposing effects on cognitive ability. The field has struggled to disentangle the effects of these two classes of genomic variants on cognitive ability from their effects on ASD susceptibility, in part because previous studies did not include controls with cognitive measures. We aim to investigate the impact of these genomic variants on ASD risk while adjusting for their known effects on cognitive ability. In a cohort of 8,426 subjects with ASD and 169,804 controls with cognitive assessments, we found that rare coding CNVs and PRS-IQ increased ASD risk, even after adjusting for their effects on cognitive ability. Bottom decile PRS-IQ and CNVs both decreased cognitive ability but had opposing effects on ASD risk. Models combining both classes of variants showed that the effects of rare CNVs and PRS-IQ on ASD risk and cognitive ability were largely additive, further suggesting that susceptibility for ASD is conferred independently from its effects on cognitive ability. Despite imparting mostly additive effects on ASD risk, rare CNVs and PRS-IQ showed opposing effects on core and associated features and developmental history among subjects with ASD. Our findings suggest that cognitive ability itself may not be the factor driving the underlying liability for ASD conferred by these two classes of genomic variants. In other words, ASD risk and cognitive ability may be two distinct manifestations of CNVs and PRS-IQ. This study also highlights the challenge of understanding how genetic risk for ASD maps onto its dimensional traits.

Identifiants

pubmed: 38751416
doi: 10.3389/fpsyt.2024.1369767
pmc: PMC11094536
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1369767

Informations de copyright

Copyright © 2024 Schmilovich, Bourque, Douard, Huguet, Poulain, Ross, Alipour, Castonguay, Younis, Jean-Louis, Saci, Pausova, Paus, Schuman, Porteous, Davies, Redmond, Harris, Deary, Whalley, Hayward, Dion, Jacquemont and Rouleau.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Zoe Schmilovich (Z)

Department of Human Genetics, McGill University, Montréal, QC, Canada.
Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.
Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.

Vincent-Raphaël Bourque (VR)

Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
Département de Pédiatrie, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Elise Douard (E)

Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
Département de Pédiatrie, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Guillaume Huguet (G)

Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.

Cécile Poulain (C)

Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
Département de Pédiatrie, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Jay P Ross (JP)

Department of Human Genetics, McGill University, Montréal, QC, Canada.
Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.

Paria Alipour (P)

Department of Human Genetics, McGill University, Montréal, QC, Canada.
Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.

Charles-Étienne Castonguay (CÉ)

Department of Human Genetics, McGill University, Montréal, QC, Canada.
Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.

Nadine Younis (N)

Département de Pédiatrie, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Martineau Jean-Louis (M)

Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.

Zohra Saci (Z)

Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.

Zdenka Pausova (Z)

The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, ON, Canada.

Tomas Paus (T)

Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
Departments of Psychiatry of Neuroscience, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.
Departments of Psychology and Psychiatry, University of Toronto, Toronto, ON, Canada.

Gunter Schuman (G)

Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.

David Porteous (D)

Lothian Birth Cohorts Group, Department of Psychology, School of Philosophy, Psychology and Language Sciences, The University of Edinburgh, Edinburgh, United Kingdom.
Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, The University of Edinburgh, Edinburgh, United Kingdom.

Gail Davies (G)

Lothian Birth Cohorts Group, Department of Psychology, School of Philosophy, Psychology and Language Sciences, The University of Edinburgh, Edinburgh, United Kingdom.

Paul Redmond (P)

Lothian Birth Cohorts Group, Department of Psychology, School of Philosophy, Psychology and Language Sciences, The University of Edinburgh, Edinburgh, United Kingdom.

Sarah E Harris (SE)

Lothian Birth Cohorts Group, Department of Psychology, School of Philosophy, Psychology and Language Sciences, The University of Edinburgh, Edinburgh, United Kingdom.

Ian J Deary (IJ)

Lothian Birth Cohorts Group, Department of Psychology, School of Philosophy, Psychology and Language Sciences, The University of Edinburgh, Edinburgh, United Kingdom.

Heather Whalley (H)

Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, The University of Edinburgh, Edinburgh, United Kingdom.

Caroline Hayward (C)

Generation Scotland, Centre for Genomic and Experimental Medicine, Institute of Genetics & Cancer, The University of Edinburgh, Edinburgh, United Kingdom.

Patrick A Dion (PA)

Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.
Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.

Sébastien Jacquemont (S)

Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montréal, QC, Canada.
Département de Pédiatrie, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.

Guy A Rouleau (GA)

Department of Human Genetics, McGill University, Montréal, QC, Canada.
Montreal Neurological Institute-Hospital, McGill University, Montréal, QC, Canada.
Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.

Classifications MeSH